These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10945302)

  • 1. Amplification of the cyclin A gene in canine and feline mammary tumors.
    Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
    J Vet Med Sci; 2000 Jul; 62(7):783-7. PubMed ID: 10945302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.
    Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
    J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of the c-yes oncogene in canine mammary tumors.
    Rungsipipat A; Tateyama S; Yamaguchi R; Uchida K; Murakami Y; Miyoshi N; Hayashi T
    J Vet Med Sci; 1999 Feb; 61(2):185-9. PubMed ID: 10081762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere length and telomerase activity in canine mammary gland tumors.
    Yazawa M; Okuda M; Setoguchi A; Iwabuchi S; Nishimura R; Sasaki N; Masuda K; Ohno K; Tsujimoto H
    Am J Vet Res; 2001 Oct; 62(10):1539-43. PubMed ID: 11592316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours.
    Millanta F; Asproni P; Canale A; Citi S; Poli A
    Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal structure of the canine oncogene, related to the human c-yes-1 oncogene, in canine mammary tumor tissue.
    Miyoshi N; Tateyama S; Ogawa K; Yamaguchi R; Kuroda H; Yasuda N; Shimizu T
    Am J Vet Res; 1991 Dec; 52(12):2046-9. PubMed ID: 1789521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in feline tumour suppressor gene p53. Mutations in an osteosarcoma and a mammary carcinoma.
    Mayr B; Reifinger M; Loupal G
    Vet J; 1998 Jan; 155(1):103-6. PubMed ID: 9455165
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel canine tumour suppressor gene p53 mutations in cases of skin and mammary neoplasms.
    Mayr B; Reifinger M; Alton K
    Vet Res Commun; 1999 Aug; 23(5):285-91. PubMed ID: 10493115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic variation in six cases of feline mammary tumours.
    Mayr B; Jugl M; Brem G; Reifinger M; Loupal G
    Zentralbl Veterinarmed A; 1999 Aug; 46(6):367-77. PubMed ID: 10481616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor.
    Kubo K; Matsuyama S; Katayama K; Tsutsumi C; Yonezawa K; Shimada T; Kotani T; Sakuma S; Ohashi F; Takamori Y
    J Vet Med Sci; 1998 Dec; 60(12):1335-40. PubMed ID: 9879535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feline STK gene expression in mammary carcinomas.
    De Maria R; Maggiora P; Biolatti B; Prat M; Comoglio PM; Castagnaro M; Di Renzo MF
    Oncogene; 2002 Mar; 21(11):1785-90. PubMed ID: 11896610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.
    Lee CH; Kweon OK
    J Vet Sci; 2002 Dec; 3(4):321-5. PubMed ID: 12819382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKM2 in Canine Mammary Tumors: Parallels to Human Breast Cancer.
    Lee HJ; Han HJ; Lee JY; Son WC
    Comp Med; 2020 Aug; 70(4):349-354. PubMed ID: 32718384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline malignant mammary tumors. I. Morphology and biology: some comparisons with human and canine mammary carcinomas.
    Weijer K; Head KW; Misdorp W; Hampe JF
    J Natl Cancer Inst; 1972 Dec; 49(6):1697-704. PubMed ID: 4346020
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.
    Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N
    PeerJ; 2024; 12():e17077. PubMed ID: 38500523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 expression in canine mammary tumors.
    Doré M; Lanthier I; Sirois J
    Vet Pathol; 2003 Mar; 40(2):207-12. PubMed ID: 12637762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-localization of PTEN and E-cadherin in canine mammary hyperplasias and benign and malignant mammary tumors.
    Asproni P; Ressel L; Millanta F; Vannozzi I; Poli A
    Res Vet Sci; 2015 Dec; 103():113-8. PubMed ID: 26679805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.
    Martin de las Mulas J; Ordás J; Millán Y; Fernández-Soria V; Ramón y Cajal S
    Breast Cancer Res Treat; 2003 Aug; 80(3):363-7. PubMed ID: 14503809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.